Episode 61: Revolutionizing Healthcare with AI: How AugiHealth Puts Patients in Control with Cameron Moulène

In this episode of The DNA of Things, host Dr. Jeremy Koenig interviews Cameron Moulène, CEO and co-founder of AugiHealth, a cutting-edge health tech startup using AI-driven digital health records to revolutionize personalized healthcare. Cameron shares his journey from actor to entrepreneur, inspired by the challenges of managing care for his autistic son. He explains how AugiHealth empowers patients to own and control their medical data, bridging gaps in a fragmented system and enabling truly proactive health management.🔑 8 Key Takeaways on AI and Patient-Owned Healthcare:The inspiration for AugiHealth came from Cameron’s personal struggle navigating disconnected healthcare systems for his son’s autism care.Most patients don’t truly own their medical records—AugiHealth is changing that with HIPAA-compliant, user-controlled digital health passports.Fragmented EHR systems create inefficiencies; AugiHealth unifies and synthesizes this data using advanced AI and large language models (LLMs).AugiHealth’s user interface is designed for simplicity, so even a 12-year-old can understand their health status, metrics, and personalized care suggestions.Predictive health analysis tools within the app allow for proactive intervention—shifting the system from sick care to preventative care.Doctors benefit too: AugiHealth gives providers a smart dashboard, with real-time biometrics and goal tracking to enhance care delivery.Ideal for families, especially parents managing children’s care—launching soon with the ability to onboard caregivers and emergency contacts.AugiHealth is free to use, reflecting the company’s mission to democratize access to better, longer, healthier lives without expensive subscriptions.Connect with Cameron LINKS:https://www.drjeremykoenig.com/https://www.instagram.com/drjeremykoenig/https://www.youtube.com/@drjeremykoenigHere's the link for this week's episode: https://drjeremykoenig.substack.com/.